510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2775-2017Class II

STOCKERT Heater-Cooler System 3T, 120V/60 Hz

LivaNova USA, Inc. / initiated 2017-06-30 / Terminated / root cause: design

Sorin Group USA, Inc. began a recall of STOCKERT Heater-Cooler System 3T, 120V/60 Hz on . FDA classified it as Class II and gives the reason as "Plastic heat exchanger fibers separating the blood compartment from the water compartment in certain oxygenators may allow diffusion of hydrogen peroxide in a quantity that exceeds allowable limits". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2775-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
LivaNova USA, Inc.
Product
STOCKERT Heater-Cooler System 3T, 120V/60 Hz
Product code
DWC Controller, Temperature, Cardiopulmonary Bypass
Reason for recall
Plastic heat exchanger fibers separating the blood compartment from the water compartment in certain oxygenators may allow diffusion of hydrogen peroxide in a quantity that exceeds allowable limits.
Root cause tag
design
FDA root cause
Device Design
Action
"Consignees were sent a recall notification, dated 06/30/2017, via mail. Instructions included a recommendation from LivaNova to use its oxygenators, or other oxygenators that are equipped with compatible heat exchangers, to ensure that the permeability rate is within the prescribed allowable limits (ALs). Depending on whether or not the oxygenator was from LivaNova, there were specific instructions to follow for each type and source. Consignees were also instructed to complete and return the Confirmation Form. If product was further distributed, the firm asks that further customers be notified of the recall and that customers contact the LivaNova Quality Assurance Team at [email protected]. Questions regarding the recall can be directed to 800-986-4702 or [email protected]. Any adverse reactions are to be reported to FDA's MedWatch Adverse Event Reporting program."
Quantity in commerce
7,546 units
Distribution
"Domestic: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, & WY. Foreign: AL, AE, AR, AT, AU, AZ, BD, BE, BG, BH, BR, BY, CA, CH, CL, CN, CO, CR, CY, CZ, DE, DK, DZ, EC, EE, EG, ES, ET, FI, FR, GB, GE, GR, GY, HK, HR, HU, IE, ID, IL, IN, IQ, IR, IT, JO, JP, KR, KW, KZ, LB, LK, LT, LU, LV, LY, MA, MC, MK, MN, MT, MU, MX, MY, NG, NL, NO, NP, NZ, OM, PA, PE, PH, PK, PL, PR, PS, PT, QA, RE, RO, RS, RU, SA, SE, SG, SK, SV, SY, TH, TN, TR, TT, TW, UA, VN, & ZA."
Product codes and lots
Item No. 16-02-85; Serial No. 16S10958-16S16847

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2775-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2771-2017Class IITerminatedVoluntary: Firm initiated
Z-2772-2017Class IITerminatedVoluntary: Firm initiated
Z-2773-2017Class IITerminatedVoluntary: Firm initiated
Z-2774-2017Class IITerminatedVoluntary: Firm initiated
Z-2775-2017Class IITerminatedVoluntary: Firm initiated
Z-2776-2017Class IITerminatedVoluntary: Firm initiated